Please login to the form below

Not currently logged in
Email:
Password:

Alzheimer

This page shows the latest Alzheimer news and features for those working in and with pharma, biotech and healthcare.

FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease

FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease

Lecanmab is being evaluated in the ongoing phase 3 Clarity Alzheimer's clinical trial. ... been waiting for new treatment options to address an underlying pathology of Alzheimer’s disease.

Latest news

More from news
Approximately 163 fully matching, plus 423 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 10 fully matching, plus 41 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 25 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....